SMTL ID : 5cy3.1

SYK catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.76 Å

Oligo State

monomer

Ligands

1 x 55Y: (5R)-5-[(1R)-1-{[6-(1-methyl-1H-pyrazol-4-yl)-2,1-benzothiazol-4-yl]oxy}ethyl]-1,3-oxazolidin-2-one(Non-covalent)

55Y.1: 19 residues within 4Å: Chain A: L.25, G.26, S.27, G.28, V.33, A.48, K.50, M.96, E.97, M.98, A.99, E.100, G.102, P.103, R.146, N.147, L.149, S.159, D.160 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.25, A:V.33, A:L.149 Hydrogen bonds: A:K.50, A:A.99, A:S.159, A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Thoma, G. et al., Orally bioavailable Syk inhibitors with activity in a rat PK/PD model. Bioorg.Med.Chem.Lett. (2015)

Release Date

2015-09-23

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence